First human trial of Buprenorphine depot injection for the maintenance treatment of opioid dependence and chronic pain

Trial Profile

First human trial of Buprenorphine depot injection for the maintenance treatment of opioid dependence and chronic pain

Planning
Phase of Trial: Phase I/II

Latest Information Update: 15 May 2017

At a glance

  • Drugs Buprenorphine (Primary)
  • Indications Pain
  • Focus Adverse reactions; First in man; Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 15 May 2017 According to BioDelivery Sciences media release, results from the first dosing cohort expected to be available in the fourth quarter
    • 17 Mar 2017 Results from the first dosing cohort are expected to be available in the third quarter of 2017, according to a BioDelivery Sciences media release.
    • 09 Nov 2016 According to BioDelivery Sciences media release, the company expects to submit the IND application before the end of 2016 and expects to initiate the trial in the first quarter of 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top